-
Wall Street Really Blew It On PTC Therapeutics
Tuesday, March 1, 2016 - 2:37pm | 305It’s been about six weeks since Credit Suisse initiated coverage of PTC Therapeutics, Inc. (NASDAQ: PTCT) with an Outperform rating and $36 price target on the stock. Now, less than two months later, the stock is down more than 76 percent and trading at $5.70 per share. On February 23, PTC...